Goldman Sachs’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Buy
+508,200
New +$13.6M ﹤0.01% 2764
2026
Q1
– Sell
-212,000
Closed -$6.88M – 6703
2025
Q4
$6.88M Buy
212,000
+112,000
+112% +$4.8M ﹤0.01% 3451
2025
Q3
$5.67M Buy
+100,000
New +$5.12M ﹤0.01% 3528

Other funds holding HIMS

Goldman Sachs's HIMS Position: Q2 2026 in Review

Goldman Sachs increased its Hims & Hers Health (HIMS) stake by 111% in Q2 2026, buying an estimated $73M and bringing the position to 5,173,865 shares worth $179M. The position accounts for 0.02% of the portfolio, ranked #829.

Goldman Sachs first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $523M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Goldman Sachs held 5,173,865 shares of Hims & Hers Health worth $179M as of Q2 2026.
  • Goldman Sachs bought 2,719,170 Hims & Hers Health shares in Q2 2026, an estimated $73M.
  • Hims & Hers Health made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #829 holding.
  • Goldman Sachs first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • Goldman Sachs's Hims & Hers Health position peaked at $523M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.